Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response

Mohamed, S.; Yasufuku, K.; Nakajima, T.; Hiroshima, K.; Kubo, R.; Iyoda, A.; Yoshida, S.; Suzuki, M.; Sekine, Y.; Shibuya, K.; Farouk, A.; Fujisawa, T.
July 2008
Thorax;Jul2008, Vol. 63 Issue 7, p642
Academic Journal
Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an accurate tool for lymph node staging of non-small cell lung cancer (NSCLC). Most patients with NSCLC require systemic chemotherapy during their treatment, with relatively poor responses. If the response to chemotherapy could be predicted, ideally at the time of the initial bronchoscopic examination, the therapeutic benefit could be maximised while limiting toxicity. A study was therefore undertaken to investigate the feasibility of EBUS-TBNA for obtaining tissue samples from mediastinal lymph nodes that can be used for immunohistochemical analysis, and to stratify patients with molecular-based pN2-NSCLC into chemoresponsive and chemoresistant subgroups who might benefit from tailoring of chemotherapy. Methods: The expression of six cell cycle-related proteins (pRb, cyclin D1, p16INK4A, p53, p21Waf1, Ki-67) in mediastinal lymph node specimens obtained by EBUS-TBNA was investigated by immunohistochemistry in 36 patients with pN2-NSCLC. Their predictive role(s) in the response to platinum-based chemotherapy was examined. Results: Immunostaining was feasible in all studied specimens. Univariate analysis revealed that p53 and p21Waf1 expressions were significantly related to the response to chemotherapy (p = 0.002 and p = 0.011, respectively). Multivariate logistic regression analysis revealed that only p53 overexpression was associated with a poor response to chemotherapy (p = 0.021). Conclusions: These results suggest that EBUS-TBNA is a feasible tool for obtaining mediastinal nodal tissue samples amenable for immunohistochemical analysis. Immunostaining of p53 in EBUS-TBNA-guided specimens may be useful in predicting the response to chemotherapy in patients with N2-NSCLC and helping in the selection of patients who might benefit from certain chemotherapeutic strategies.


Related Articles

  • Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. Olson, Timothy S.; Bamias, Giorgos; Naganuma, Makoto; Rivera-Nieves, Jesus; Burcin, Tracy L.; Ross, William; Morris, Margaret A.; Pizarro, Theresa T.; Ernst, Peter B.; Cominelli, Fabio; Ley, Klaus; Rivera-Nieves, Jesús // Journal of Clinical Investigation;Aug2004, Vol. 114 Issue 3, p389 

    SAMP1/YitFc mice develop discontinuous, transmural inflammatory lesions in the terminal ileum, similar to what is found in human Crohn disease. Compared with the mesenteric lymph nodes (MLNs) of AKR control mice, SAMP1/YitFc MLNs contain a 4.3-fold expansion in total B cell number and a 2.5-fold...

  • Parvovirus B19 detected in Rosai–Dorfman disease in nodal and extranodal manifestations. Y Mehraein // Journal of Clinical Pathology;Dec2006, Vol. 59 Issue 12, p1320 

    Sinus histiocytosis with massive lymphadenopathy (SHML), also designated as Rosai–Dorfman disease (RDD), is a rare benign reactive lymphoproliferative disorder. It is defined by a characteristic histopathology with sinus histiocytosis and haemophagocytosis known as emperipolesis. In...

  • Multicentric Castleman's disease in a child with subpectoral involvement. Koşucu, Polat; Ahmeto&gcaron;lu, Ali; İmamo&gcaron;lu, Mustafa; Çay, Ali; Çobano&gcaron;lu, Ümit; Gümele, Halit Reşit; Koşucu, Polat; Ahmetoğlu, Ali; Imamoğlu, Mustafa; Cay, Ali; Cobanoğlu, Umit; Gümele, Halit Reşit // Pediatric Radiology;Aug2003, Vol. 33 Issue 8, p570 

    Castleman's disease is a benign lymphoproliferative disorder characterised by enlarged hyperplastic lymph nodes. It is rare in children and usually presents as localised disease. Subpectoral involvement has not been previously described in multicentric Castleman's disease in children. We present...

  • Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. Van den Eynden, G. G.; Van der Auwera, I.; Van Laere, S. J.; Huygelen, V.; Colpaert, C. G.; van Dam, P.; Dirix, L. Y.; Vermeulen, P. B.; Van Marck, E. A. // British Journal of Cancer;11/20/2006, Vol. 95 Issue 10, p1362 

    We studied the presence of lymphangiogenesis in lymph node (LN) metastases of breast cancer. Lymph vessels were present in 52 of 61 (85.2%) metastatically involved LNs vs 26 of 104 (25.0%) uninvolved LNs (P<0.001). Furthermore, median intra- and perinodal lymphatic endothelial cell proliferation...

  • Advances in cutaneous lymphoproliferative disorders. Pimpinelli, N. // Journal of Investigative Dermatology;Nov2004, Vol. 123 Issue 5, pA87 

    The most recent advances in cutaneous lymphoma (CL) concern molecular diagnosis (including its relevance to staging), new clinico-pathologic entities, and treatment modalities. The main topics of interest in the molecular diagnosis of CL are early lesions and early involvement of lymph nodes and...

  • The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation. Luci Bavaresco; Andressa Bernardi; Elizandra Braganhol; Angélica Cappellari; Liliana Rockenbach; Patrícia Farias; Márcia Wink; Andrés Delgado-Cañedo; Ana Battastini // Molecular & Cellular Biochemistry;Dec2008, Vol. 319 Issue 1/2, p61 

    Abstract  Malignant gliomas are the most common and devastating primary tumors in the brain and, despite treatment, patients with these tumors have a poor prognosis. The participation of ecto-5′-NT/CD73 per se as a proliferative factor, being involved in the control of cell growth,...

  • Primary Digestive Richter’s Syndrome. Parrens, Marie; Sawan, Bassem; Dubus, Pierre; Lacombe, Francis; Marit, Gérald; Vergier, Béatrice; Reiffers, Josy; de Mascarel, Antoine; Merlio, Jean Philippe // Modern Pathology;May2001, Vol. 14 Issue 5, p452 

    The clinical and morphologic transformation of 3 to 5% of chronic lymphocytic leukemia (CLL) to diffuse large-cell lymphoma (DLCL) is commonly referred to as Richter’s syndrome. Richter’s syndrome occurs mostly in lymph nodes and may represent a second neoplasm or a transformation...

  • Lokal Ä°leri Evre Meme Kanserlerinde Meme Koruyucu Cerrahi ve Sentinel Lenf Nodu Örneklemesi: Tek Merkez Deneyimi. Sezer, Atakan; Alas, Ruşen Coşar; Cicin, İrfan; Hoşcoşkun, Zeki; Tunçbilek, Nermin // Balkan Medical Journal;Jun2011, Vol. 28 Issue 2, p138 

    Objective: Patients with locally advanced breast cancer may undergo breast conserving surgery after neoadjuvant chemotherapy. The aim of the study is to evaluate the results of locally advanced breast cancer patients who underwent breast conserving surgery, axi l l a ry dissection and sentinel...

  • Inhibitors of phosphatidylinositol 3-kinase activity prevent cell cycle progression and induce apoptosis at the M/G1 transition in CHO cells. Opstal, A.; Boonstra, J. // Cellular & Molecular Life Sciences;Jan2006, Vol. 63 Issue 2, p220 

    Phosphatidylinositol 3-kinase (PI3-kinase) activity has been implicated in regulating cell cycle progression at distinct points in the cell cycle by preventing cell cycle arrest or apoptosis. In this study, the role of PI3-kinase activity during the entire G1 phase of the ongoing cell cycle was...


Read the Article


Sign out of this library

Other Topics